共 131 条
- [1] Papa MZ(2008)Timing of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy for breast cancer J Surg Oncol 98 403-406
- [2] Zippel D(2013)Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study Lancet Oncol 14 609-18
- [3] Kaufman B(2014)Feasibility and accuracy of sentinel lymph node biopsy in clinically node-positive breast cancer after neoadjuvant chemotherapy: a meta-analysis PLoS One 9 23-29
- [4] Shimon-Paluch S(2015)Selective sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer: results of the GEICAM 2005–07 study[J] Cir Esp 93 1455-61
- [5] Yosepovich A(2013)Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial JAMA 310 9304-11
- [6] Oberman B(2005)Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy J Clin Oncol 23 2884-9
- [7] Kuehn T(2010)Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer Cancer 116 228-47
- [8] Bauerfeind I(2009)New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 7703-20
- [9] Fehm T(2005)American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer J Clin Oncol 23 1255-63
- [10] Fleige B(2007)Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases Cancer 109 2946-52